Disclaimer:
For research use only. Not for human consumption. Intended for laboratory-based studies by qualified professionals. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Overview:
Tirzepatide is a dual incretin mimetic peptide studied for its potent effects on metabolic regulation, appetite suppression, and insulin sensitivity. It acts as a dual agonist at both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, offering a next-generation approach to weight managementand glycemic control in metabolic research models.
Mechanism of Action:
Tirzepatide activates two key incretin pathways:
The combination of these pathways has been shown to synergistically improve glucose tolerance, energy expenditure, and body composition, making Tirzepatide one of the most powerful metabolic peptides in current research.
Research Highlights:
Specifications:
Form: Lyophilized powder (research-grade)
Purity: ≥98% (HPLC-tested)
Storage: Store refrigerated (2–8 °C), protected from light and humidity.
Disclaimer:
For research use only. Not for human consumption. Intended exclusively for qualified laboratory professionals conducting controlled metabolic and endocrinological studies.
FAQ
What is tirzepatide studied for in research models?
Tirzepatide is studied for its role in dual incretin receptor signaling and downstream metabolic pathway modulation in preclinical research.
Is tirzepatide intended for human use?
No. This product is for laboratory research use only and not intended for human consumption.
Reviews
There are no reviews yet.